Lacticaseibacillus rhamnosus LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial.
- 2024-11-15
- RCT
- Frontiers in nutrition 11
- Ke Chen
- Kaihong Zeng
- Shanshan Jin
- Yu Ma
- Limei Cai
- Ping Xu
- Yang Nie
- Li Luo
- Qinghua Yu
- Changqi Liu
- PubMed: 39619284
- DOI: 10.3389/fnut.2024.1479186
- High evidence
More children in the IG showed improvements in diarrhea than those in the CG for both per protocol analysis (70.2 vs. 46.3%, p = 0.01) and intention-to-treat analysis (66.7 vs. 41.7%, p = 0.003).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 5 × 10^9 CFU/day